Picture of Cell Source logo

CLCS Cell Source Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Cell Source, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-4.48-4.56-5.47-5.17-5.32
Non-Cash Items1.321.361.390.4660.755
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.570.4230.7011.562.22
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-2.59-2.77-3.38-3.14-2.35
Financing Cash Flow Items0.086-0.04-0.353-0.028-0.279
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.62.993.233.272.15
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.0090.217-0.1520.13-0.2